These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9831696)
1. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy. Sørensen VB; Rossing P; Tarnow L; Parving H; Nørgaard T; Kastrup J Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696 [TBL] [Abstract][Full Text] [Related]
2. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341 [TBL] [Abstract][Full Text] [Related]
3. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106 [TBL] [Abstract][Full Text] [Related]
4. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy. Tarnow L; Sato A; Ali S; Rossing P; Nielsen FS; Parving HH Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934 [TBL] [Abstract][Full Text] [Related]
5. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy: response to Tarnow et al. Cooper ME Diabetes Care; 2000 Dec; 23(12):1723-4. PubMed ID: 11128340 [No Abstract] [Full Text] [Related]
6. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study. O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924 [TBL] [Abstract][Full Text] [Related]
7. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group. Ruddy TD; Fodor JG Cardiovasc Drugs Ther; 1997 Sep; 11(4):581-90. PubMed ID: 9358963 [TBL] [Abstract][Full Text] [Related]
8. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial. Estacio RO; Schrier RW Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137 [TBL] [Abstract][Full Text] [Related]
11. Decreased distensibility of resistance vessels of the skin in type 1 (insulin-dependent) diabetic patients with microangiopathy. Kastrup J; Nørgaard T; Parving HH; Lassen NA Clin Sci (Lond); 1987 Jan; 72(1):123-30. PubMed ID: 3802718 [TBL] [Abstract][Full Text] [Related]
12. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study. Poulsen PL; Ebbehøj E; Mogensen CE J Intern Med; 2001 May; 249(5):433-40. PubMed ID: 11350567 [TBL] [Abstract][Full Text] [Related]
13. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial. Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E; Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518 [TBL] [Abstract][Full Text] [Related]
14. Renal protection in diabetes: an emerging role for calcium antagonists. Parving HH; Tarnow L; Rossing P J Hypertens Suppl; 1996 Nov; 14(4):S21-5. PubMed ID: 8986939 [TBL] [Abstract][Full Text] [Related]
15. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. Asberg A; Midtvedt K; Vassbotn T; Hartmann A Nephrol Dial Transplant; 2001 Jul; 16(7):1465-70. PubMed ID: 11427642 [TBL] [Abstract][Full Text] [Related]
16. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial. Schrier RW; Estacio RO; Jeffers B Diabetologia; 1996 Dec; 39(12):1646-54. PubMed ID: 8960857 [TBL] [Abstract][Full Text] [Related]
17. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [TBL] [Abstract][Full Text] [Related]
18. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus]. Sjølie AK; Chaturvedi N; Fuller J Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804 [TBL] [Abstract][Full Text] [Related]
19. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P Eur J Clin Pharmacol; 2005 Aug; 61(7):483-90. PubMed ID: 16021438 [TBL] [Abstract][Full Text] [Related]
20. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study. Rossing K; Christensen PK; Jensen BR; Parving HH Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]